Where does Pacesetter, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Pacesetter, Inc. ranks #591 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Pacesetter, Inc. hold?

Pacesetter, Inc. holds 754 US utility patents granted between 2015 and 2025, spanning 60 technology areas.

What is Pacesetter, Inc.'s Innovation Score?

Pacesetter, Inc. has an Innovation Score of 66.2 out of 100 (top 1% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Pacesetter, Inc.'s patent grant rate increasing or decreasing?

Pacesetter, Inc.'s recent grant velocity is +16% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Pacesetter, Inc.'s patents?

Pacesetter, Inc.'s patents average 17.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Pacesetter, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Pacesetter, Inc.

Q: What technology areas does Pacesetter, Inc. focus on?

Pacesetter, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 609 patents. Grants appear in 60 CPC subclasses total.

USPTO PatentsView assignee record - 754 granted patents across 60 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Pacesetter ranks #591 of 49,997 tracked US assignees by granted-patent volume, with 754 patents across 60 technology areas.

#591
of 49,997 US assignees by volume: Top 1%
by Innovation Score (66.2/100): 17.8
avg claims per patent: +16%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R591 · US Corporation #591 · 754 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MID 754 grants
TOP-DECILE #591/49,997
PHOTO-FINISH adidas
CPC-WIDE A61N · 60 areas
INNOV-STRONG 66.2/100
CLAIMS-RICH 17.8 claims/avg
TYPE-USCORP US Corporation
VEL-UP +16% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: adidas AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
X Development · near

66
Dana Italia S R L · near

66
Pacesetter · this assignee

66
Kuwait University · near

66
Rogers · near

66
3D Lighting… · lowest

7

What this shows Pacesetter's Innovation Score is 66.2/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

How Pacesetter's grant cadence moved

Between 2020–2024, Pacesetter, Inc. received 374 grants versus 322 in 2015–2019 (+16% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2023 at 88 grants and bottomed in 2017 at 50. Lead class A61N accounts for 80.8% of the portfolio across 60 subclasses. Volume neighbours: Cochlear Limited (#586) and Spigen Korea Co., Ltd. (#594).

Pacesetter's three-year grant acceleration

From 2019–2021 to 2022–2024, Pacesetter, Inc. moved from 201 to 229 grants (1.14x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #890. See the growth leaderboard.

Cochlear

768
Mellanox

766
Mediatek Singapor…

761
Hanon Systems

758
adidas

754
Pacesetter ◀

754
Medline Industries

753
Shenzhen Goodix T…

753
Spigen Korea

749

What this shows Pacesetter holds 754 patents at rank #590, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Pacesetter

By rank, the assignees closest to #590 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Pacesetter's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Pacesetter, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (66 here).

Dana Italia S.R.L. 66 Rogers Corporation 66 Kuwait University 66 X Development LLC 66

Similar claim depth

Nearest assignees by average claims per patent (17.8 here).

Verizon Digital Media Services Inc. 17.8 avg Novamont S.p.A. 17.8 avg Csem Centre Suisse D'electronique ET DE Microtechnique SA—RECHERCHE ET DÉVELOPPEMENT 17.8 avg University of Leeds 17.8 avg

Pacesetter's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

66 Top 1% higher than 99% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Pacesetter, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	82	10.9%
2016	78	10.3%
2017	50	6.6%
2018	56	7.4%
2019	56	7.4%
2020	79	10.5%
2021	66	8.8%
2022	64	8.5%
2023	88	11.7%
2024	77	10.2%
2025partial year	58	7.7%

Which technologies does Pacesetter, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 609

A61B - DIAGNOSIS; SURGERY; Identification 369

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 76

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 70

H01G - CAPACITORS; Capacitors, Rectifiers, Detectors, Switching Devices, Light-sensitive OR Temperature-sensitive Devices OF THE Electrolytic Type 55

H04W - Wireless Communication Networks 54

H04B - Transmission 32

H01M - Processes OR Means, e.g. Batteries, FOR THE Direct Conversion OF Chemical Energy Into Electrical Energy 26

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 24

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 23

H01Q - Antennas, i.e. Radio Aerials 21

C25F - Processes FOR THE Electrolytic Removal OF Materials From OBJECTS; Apparatus Therefor 20

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 15

G06F - Electric Digital Data Processing 15

Y10T - Technical Subjects Covered BY Former US Classification 13

Top 15 of 60 technology areas

Where it ranks

Overall rank by patents

#591

of 49,997 tracked assignees

Innovation Score

66.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Pacesetter, Inc.'s patent record in context - here's where to go next.

Pacesetter, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 80.8% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #591 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Pacesetter, Inc. against Cochlear Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 66.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.